SCHEMBL5159768

SCHEMBL5159768

O=c1[nH]c2c(C(F)(F)F)cccc2c(-c2cc(Cl)ccc2O)c1-c1ccc(O)cc1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 4/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
CAPN1 P07384 1/20 0.40
EEF2K O00418 1/20 0.40
PLK4 O00444 1/20 0.40
IKBKB O14920 1/20 0.40
DYRK3 O43781 1/20 0.40
PIM1 P11309 1/20 0.40
CDK2 P24941 1/20 0.40
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
CLK2 P49760 1/20 0.40
GSK3B P49841 1/20 0.40
IRAK1 P51617 1/20 0.40
RPS6KA3 P51812 1/20 0.40
NEK4 P51957 1/20 0.40
PLK1 P53350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5159726 0.90 CYP2C9 (0.42) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5159401 0.84 CAPN1 (0.44) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5160100 0.84 CAPN1 (0.41) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5162957 0.83 CYP2C9 (0.55) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5157473 0.83 CYP2C9 (0.48) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5162380 0.81 CYP2C9 (0.52) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5161821 0.80 CYP2C9 (0.66) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5157936 0.80 CYP2C9 (0.40) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5157826 0.79 CYP2C9 (0.48) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL5159329 0.79 CYP2C9 (0.58) CYP2C9CYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1133474-B1 3-SUBSTITUTED-4-ARYLQUINOLIN-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2007-02-21 EP claimed